COMPETITION: Investigation of clinical endpoints for treatment-induced gastroesophageal reflux disease (GERD) symptom changes.

Trial Profile

COMPETITION: Investigation of clinical endpoints for treatment-induced gastroesophageal reflux disease (GERD) symptom changes.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Jun 2013

At a glance

  • Drugs Pantoprazole (Primary)
  • Indications Gastro-oesophageal reflux
  • Focus Therapeutic Use
  • Acronyms COMPETITION
  • Sponsors Takeda Global Research and Development Center
  • Most Recent Events

    • 04 May 2012 Additional company (Takeda Global Research and Development Center) added in association as reported by ClinicalTrials.gov.
    • 09 Oct 2008 Actual end date (Apr 2007) added as reported by ClinicalTrials.gov.
    • 09 Oct 2008 Actual patient number (628) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top